Sage Mountain Advisors’s Celularity CELU Stock Holding History

Sage Mountain Advisors’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,277	Closed	-$470K	–	463
2020 Q4	$470K	Buy	+4,277	New	+$455K	0.15%	97

Other funds holding CELU

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

Sage Mountain Advisors's CELU Position: Q1 2021 in Review

Sage Mountain Advisors sold out of Celularity (CELU) in Q1 2021, closing a stake of 4,277 shares — an estimated $470K sold.

Sage Mountain Advisors first reported a position in CELU in Q4 2020 and held it in 1 quarter. The position peaked at $470K in Q4 2020. 63 funds tracked by Wall St. Rank hold CELU as of Q1 2021.

Sage Mountain Advisors reported no remaining Celularity position as of Q1 2021 after selling out during the quarter.
Sage Mountain Advisors sold 4,277 Celularity shares in Q1 2021, an estimated $470K.
Sage Mountain Advisors first reported a position in Celularity in Q4 2020 and held it in 1 quarter.
Sage Mountain Advisors's Celularity position peaked at $470K in Q4 2020.
63 funds tracked by Wall St. Rank held Celularity as of Q1 2021.

Based on Sage Mountain Advisors's 13F filing for Q1 2021, filed 10 May 2021.